<bill session="112" type="s" number="2295" updated="2013-07-20T02:36:24-04:00">
  <state datetime="2012-04-18">REFERRED</state>
  <status>
    <introduced datetime="2012-04-18"/>
  </status>
  <introduced datetime="2012-04-18"/>
  <titles>
    <title as="introduced" type="short">Patient Safety and Generic Labeling Improvement Act</title>
    <title as="introduced" type="official">A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.</title>
  </titles>
  <sponsor id="300065"/>
  <cosponsors>
    <cosponsor id="412326" joined="2012-04-19"/>
    <cosponsor id="300009" joined="2012-04-18"/>
    <cosponsor id="412490" joined="2012-04-18"/>
    <cosponsor id="400050" joined="2012-04-18"/>
    <cosponsor id="412390" joined="2012-04-18"/>
    <cosponsor id="412378" joined="2012-04-18"/>
    <cosponsor id="412247" joined="2012-04-18"/>
  </cosponsors>
  <actions>
    <action datetime="2012-04-18">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S2497-2498, S2499-2500"/>
    </action>
    <action state="REFERRED" datetime="2012-04-18">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S2498" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="112" type="h" number="4384"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary>4/18/2012--Introduced.
Patient Safety and Generic Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) to change the labeling of a drug so approved in the same manner authorized by regulation for the holder of an approved new drug application. Allows conforming changes to be ordered to the labeling of the equivalent listed drug and each drug approved under the abbreviated new drug application process that corresponds to such listed drug.</summary>
</bill>
